AKT1(low) quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer

BACKGROUND: Absence of pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) correlates with poor long-term survival in patients with triple negative breast cancer (TNBC). These incomplete treatment responses are likely determined by mechanisms that enable cancer cells to resist bein...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabraji, Sheheryar, Solé, Xavier, Huang, Ying, Bango, Clyde, Bowden, Michaela, Bardia, Aditya, Sgroi, Dennis, Loda, Massimo, Ramaswamy, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540189/
https://www.ncbi.nlm.nih.gov/pubmed/28764807
http://dx.doi.org/10.1186/s13058-017-0877-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540189/
https://www.ncbi.nlm.nih.gov/pubmed/28764807
http://dx.doi.org/10.1186/s13058-017-0877-7

Ejemplares similares